The Shares of a small-cap tech firm were locked in the upper circuit for the 19th straight session after it announced its ...

During Wednesday’s trading session, shares of a leading end-to-end IoT solutions-enabled integrated electronics manufacturer ...

The shares of the prominent infrastructure company gained up to 4 percent in today’s trading session after the company bagged ...

The shares of prominent pharmaceutical companies gained up to 4 percent in today’s trading session after the company signed ...

The FIFA Club World Cup 2025 is historic because it’s the first time the tournament is being played with 32 clubs, instead of the old format of just 7 teams. The tournament is happening in the United ...

Top Stock Brokers in India: Are you looking to open your demat and trading account, but confused about which stockbroker to choose? We have got you covered in this post. Today, we are going to discuss ...

Top 7 Hybrid Mutual Funds to Invest In 2025 1. JM Aggressive Hybrid Fund 1-Year Return: 6.77% 3-Year Return: 24.27% 5-Year Return: 28.07% Expense ratio: 0.56% as of 31st May 2025 Strong long-term ...

Top Conglomerates in India: It has been almost three decades since the Indian economy underwent liberalization and privatization and opened up to the world. Since then we have evolved into a $3 ...

Today, we recommend two stocks, one from the healthcare sector and another from the railways sector, recommended by the Trade Brains Portal, to buy for an upside of up to 21%. We also analyzed the ...

Advice for Consumers in the New Regulatory Environment Always check the welcome kit and fee schedule. Be a credit card user, not an abuser—it’s easy to fall into the trap of unsolicited offers. Look ...

Emkay Global values the residential business using an embedded EV/EBITDA multiple and the commercial business on a cap-rate basis. With a net debt of around Rs.35 billion (as of Mar-26E), they set a ...

Shares of a leading pharmaceutical company rose nearly 2 percent in today’s trading session after the firm announced it had secured regulatory approval for its new diabetes drug. The development marks ...